Search

Author/Creator Breder, Valery

1. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial. Issue 8 (August 2022)

Authors:
Kelley, Robin Kate; Rimassa, Lorenza; Cheng, Ann-Lii; Kaseb, Ahmed; Qin, Shukui; Zhu, Andrew X; Chan, Stephen L; Melkadze, Tamar; Sukeepaisarnjaroen, Wattana; Breder, Valery; Verset, Gontran; Gane, Edward; Borbath, Ivan; Rangel, Jose David Gomez; Ryoo, Baek-Yeol; Makharadze, Tamta; Merle, Philipp...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 8(2022)
Page Start:
995
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial. (August 2021)

Authors:
Vogel, Arndt; Qin, Shukui; Kudo, Masatoshi; Su, Yun; Hudgens, Stacie; Yamashita, Tatsuya; Yoon, Jung-Hwan; Fartoux, Laetitia; Simon, Krzysztof; López, Carlos; Sung, Max; Mody, Kalgi; Ohtsuka, Tatsuroh; Tamai, Toshiyuki; Bennett, Lee; Meier, Genevieve; Breder, Valery
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 6:Number 8(2021)
Page Start:
649
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions. Issue 1 (December 2017)

Authors:
Ivanov, Maxim; Laktionov, Konstantin; Breder, Valery; Chernenko, Polina; Novikova, Ekaterina; Telysheva, Ekaterina; Musienko, Sergey; Baranova, Ancha; Mileyko, Vladislav
Journal:
Journal of translational medicine
Issue:
Volume 15:Issue 1(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗